2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Revenue | CN¥8.6B | CN¥4B | CN¥4.5B | CN¥3.4B | CN¥4.9B |
Cost of Revenue | CN¥665M | CN¥1.1B | CN¥761M | CN¥777M | CN¥976M |
Gross Profit | CN¥8B | CN¥2.9B | CN¥3.7B | CN¥2.7B | CN¥3.9B |
Gross Profit % | 92% | 72% | 83% | 77% | 80% |
R&D Expenses | CN¥0 | CN¥0 | CN¥208M | CN¥152M | CN¥149M |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Net Income | CN¥1.2B | -CN¥693M | CN¥1B | CN¥1.2B | CN¥2.1B |
Dep. & Amort. | CN¥395M | CN¥327M | CN¥140M | CN¥53M | CN¥25M |
Def. Tax | CN¥0 | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
Stock Comp. | CN¥44M | CN¥14M | CN¥19M | CN¥22M | CN¥6.8M |
Chg. in WC | -CN¥2.5B | -CN¥152M | -CN¥1.5B | CN¥467M | -CN¥352M |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Cash | CN¥3.2B | CN¥2.5B | CN¥2.9B | CN¥4.3B | CN¥5.8B |
ST Investments | CN¥461M | CN¥176M | CN¥177M | CN¥973M | CN¥514M |
Cash & ST Inv. | CN¥3.7B | CN¥2.6B | CN¥3B | CN¥5.2B | CN¥6.2B |
Receivables | CN¥2.6B | CN¥2.6B | CN¥3.7B | CN¥2B | CN¥2B |
Inventory | -CN¥42M | CN¥1 | -CN¥493M | CN¥1 | CN¥0 |
The company reported strong financial performance for 2024, with total loan volume reaching RMB 53.6 billion, a 49% year-over-year increase, surpassing internal targets.
AI integration across operations led to significant cost savings and efficiency improvements, with RMB 44 million saved in funding allocation and RMB 9 million in labor costs for the year.
The international business achieved profitability in The Philippines and is expected to double loan volume in 2025, with plans to replicate this success in other regions.
The insurance brokerage segment faced challenges with a 10% decline in total premiums for 2024 but showed strong renewal rates and growth in digital client acquisition.
The company announced a cash dividend of USD 0.22 per ADS for the second half of 2024 and provided 2025 revenue guidance of RMB 5.6 billion to RMB 6.5 billion, reflecting continued growth expectations.